advertisement
advertisement
advertisement
  • 11.04.16

Nestle partners with Aimmune on food allergy research 

Nestle Health Sciences, part of Nestle’s R&D arm, is investing $145 million into food allergy research through a partnership with Aimmune, a therapeutics company that is working on a treatment candidate for peanut allergies. 

It has been estimated that more than 30 million people in the United States and Europe have a food allergy. CF